Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 631 AL 645

Sleep Biomarkers for Predicting Cognitive Decline and Alzheimer's Disease: A Systematic Review of Longitudinal Studies

Carpi M, Fernandes M, Mercuri NB, Liguori C.

J Alzheimers Dis. 2024;97(1):121-143. doi: 10.3233/JAD-230933.

Correlation Between Amyloid PET Imaging and Discordant Cerebrospinal Fluid Biomarkers Results in Patients with Suspected Alzheimer's Disease

Lojo-Ramírez JA, Guerra-Gómez M, Marín-Cabañas AM, Fernández-Rodríguez P, Bernal Sánchez-Arjona M, Franco-Macías E, García-Solís D.

J Alzheimers Dis. 2024;97(1):447-458. doi: 10.3233/JAD-230744.

Navigating the dementia landscape: Biomarkers and emerging therapies

Maheshwari S, Singh A, Ansari VA, Mahmood T, Wasim R, Akhtar J, Verma A.

Ageing Res Rev. 2024 Feb;94:102193. doi: 10.1016/j.arr.2024.102193. Epub 2024 Jan 10.

Degeneration of the cholinergic system in individuals with subjective cognitive decline: A systematic review

Rodriguez-Hernandez MA, Alemany I, Olofsson JK, Diaz-Galvan P, Nemy M, Westman E, Barroso J, Ferreira D, Cedres N.

Neurosci Biobehav Rev. 2024 Feb;157:105534. doi: 10.1016/j.neubiorev.2024.105534. Epub 2024 Jan 14.

Application of Suggestive Biomarkers in Dementia With Lewy Bodies With Masking of Typical Clinical Symptoms by Alzheimer Disease-type Pathology

Kobayashi R, Morioka D, Kawakatsu S, Sakamoto K, Suzuki A.

Alzheimer Dis Assoc Disord. 2024 Jan-Mar 01;38(1):95-97. doi: 10.1097/WAD.0000000000000597. Epub 2024 Jan 17.

Monitoring synaptic pathology in Alzheimer's disease through fluid and PET imaging biomarkers: a comprehensive review and future perspectives

Lista S, Santos-Lozano A, Emanuele E, Mercuri NB, Gabelle A, López-Ortiz S, Martín-Hernández J, Maisto N, Imbimbo C, Caraci F, Imbimbo BP, Zetterberg H, Nisticò R.

Mol Psychiatry. 2024 Mar;29(3):847-857. doi: 10.1038/s41380-023-02376-6. Epub 2024 Jan 16.

The Room Where It Happens: Clinician Reflections on Returning Preclinical Alzheimer's Biomarker Results to Research Participants

Erickson CM, Chin NA, Ketchum FB, Eveler ML, Conway CE, Coughlin DM, Clark LR.

J Prev Alzheimers Dis. 2024;11(1):1-6. doi: 10.14283/jpad.2023.88.

Digital Clock Drawing as an Alzheimer's Disease Susceptibility Biomarker: Associations with Genetic Risk Score and APOE in Older Adults

Thompson LI, Cummings M, Emrani S, Libon DJ, Ang A, Karjadi C, Au R, Liu C.

J Prev Alzheimers Dis. 2024;11(1):79-87. doi: 10.14283/jpad.2023.48.

Induced pluripotent stem cell models as a tool to investigate and test fluid biomarkers in Alzheimer's disease and frontotemporal dementia

McInvale JJ, Canoll P, Hargus G.

Brain Pathol. 2024 Jul;34(4):e13231. doi: 10.1111/bpa.13231. Epub 2024 Jan 21.

Blood-based biomarkers in Alzheimer's disease - moving towards a new era of diagnostics

Arslan B, Zetterberg H, Ashton NJ.

Clin Chem Lab Med. 2024 Jan 23;62(6):1063-1069. doi: 10.1515/cclm-2023-1434. Print 2024 May 27.

Blood Biomarkers of Alzheimer's Disease and Cognition: A Literature Review

Garcia-Escobar G, Manero RM, Fernández-Lebrero A, Ois A, Navalpotro-Gómez I, Puente-Periz V, Contador-Muñana J, Estragués-Gazquez I, Puig-Pijoan A, Jiménez-Balado J.

Biomolecules. 2024 Jan 11;14(1):93. doi: 10.3390/biom14010093.

Salivary Biomarkers for Alzheimer's Disease: A Systematic Review with Meta-Analysis

Nijakowski K, Owecki W, Jankowski J, Surdacka A.

Int J Mol Sci. 2024 Jan 18;25(2):1168. doi: 10.3390/ijms25021168.

Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis

Chapleau M, La Joie R, Yong K, Agosta F, Allen IE, Apostolova L, Best J, Boon BDC, Crutch S, Filippi M, Fumagalli GG, Galimberti D, Graff-Radford J, Grinberg LT, Irwin DJ, Josephs KA, Mendez MF, Mendez PC, Migliaccio R, Miller ZA, Montembeault M, Murray ME, Nemes S, Pelak V, Perani D, Phillips J, Pijnenburg Y, Rogalski E, Schott JM, Seeley W, Sullivan AC, Spina S, Tanner J, Walker J, Whitwell JL, Wolk DA, Ossenkoppele R, Rabinovici GD; PCA International Work Group.

Lancet Neurol. 2024 Feb;23(2):168-177. doi: 10.1016/S1474-4422(23)00414-3.

A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer's disease

van Dyck CH, Mecca AP, O'Dell RS, Bartlett HH, Diepenbrock NG, Huang Y, Hamby ME, Grundman M, Catalano SM, Caggiano AO, Carson RE.

Alzheimers Res Ther. 2024 Jan 25;16(1):20. doi: 10.1186/s13195-024-01382-2.

Multi-Omic Blood Biomarkers as Dynamic Risk Predictors in Late-Onset Alzheimer's Disease

Bhalala OG, Watson R, Yassi N.

Int J Mol Sci. 2024 Jan 19;25(2):1231. doi: 10.3390/ijms25021231.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias